BACKGROUND: Facial composite tissue allotransplantation is a potential reconstructive option for severe facial disfigurement. The purpose of the present investigation was to use decision analysis modelling to ascertain the expected quality-adjusted life years (QALYs) gained with face transplantation (versus remaining in a disfigured state) in an effort to assist surgeons with the decision of whether to adopt this procedure. STUDY DESIGN: The probabilities of potential complications associated with facial allotransplantation were identified by a comprehensive review of kidney and hand transplant literature. A decision analysis tree illustrating possible health states for face allotransplantation was then constructed. Utilities were obtained from 30 participants, using the standard gamble and time trade-off measures. The utilities were then translated into QALYs, and the expected QALYs gained with transplantation were computed. RESULTS: Severe facial deformity was associated with an average of 7.34 QALYs. Allotransplantation of the face imparted an expected gain in QALYs of between 16.2 and 27.3 years. CONCLUSIONS: The current debate within the medical community surrounding facial composite tissue allotransplantation has centred on the issue of inducing a state of immunocompromise in a physically healthy individual for a non-life-saving procedure. However, the latter must be weighed against the potential social and psychological benefits that transplantation would confer. As demonstrated by a gain of 26.9 QALYs, participants' valuation of quality of life is notably greater for face transplantation with its side effects of immunosuppression than for a state of uncompromised physical health with severe facial disfigurement.
BACKGROUND: Facial composite tissue allotransplantation is a potential reconstructive option for severe facial disfigurement. The purpose of the present investigation was to use decision analysis modelling to ascertain the expected quality-adjusted life years (QALYs) gained with face transplantation (versus remaining in a disfigured state) in an effort to assist surgeons with the decision of whether to adopt this procedure. STUDY DESIGN: The probabilities of potential complications associated with facial allotransplantation were identified by a comprehensive review of kidney and hand transplant literature. A decision analysis tree illustrating possible health states for face allotransplantation was then constructed. Utilities were obtained from 30 participants, using the standard gamble and time trade-off measures. The utilities were then translated into QALYs, and the expected QALYs gained with transplantation were computed. RESULTS: Severe facial deformity was associated with an average of 7.34 QALYs. Allotransplantation of the face imparted an expected gain in QALYs of between 16.2 and 27.3 years. CONCLUSIONS: The current debate within the medical community surrounding facial composite tissue allotransplantation has centred on the issue of inducing a state of immunocompromise in a physically healthy individual for a non-life-saving procedure. However, the latter must be weighed against the potential social and psychological benefits that transplantation would confer. As demonstrated by a gain of 26.9 QALYs, participants' valuation of quality of life is notably greater for face transplantation with its side effects of immunosuppression than for a state of uncompromised physical health with severe facial disfigurement.
Entities:
Keywords:
Decision analysis; Facial transplantation; Quality-adjusted life years
Authors: Manuel Pascual; Tom Theruvath; Tatsuo Kawai; Nina Tolkoff-Rubin; A Benedict Cosimi Journal: N Engl J Med Date: 2002-02-21 Impact factor: 91.245
Authors: David O Taylor; Leah B Edwards; Mark M Boucek; Elbert P Trulock; Mario C Deng; Berkeley M Keck; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2005-08 Impact factor: 10.247
Authors: Yves Vanrenterghem; Johannes P van Hooff; Jean-Paul Squifflet; Kaija Salmela; Paolo Rigotti; Rahul M Jindal; Julio Pascual; Henrik Ekberg; Luis Sanchez Sicilia; John N Boletis; Josep M Grinyo; Manuel Arias Rodriguez Journal: Am J Transplant Date: 2005-01 Impact factor: 8.086
Authors: Warren C Breidenbach; Gordon R Tobin; Vijay S Gorantla; Ruben N Gonzalez; Darla K Granger Journal: J Hand Surg Am Date: 2002-09 Impact factor: 2.230
Authors: Nasimul Ahsan; Michael J Holman; Mark V Jarowenko; Mohammad S Razzaque; Harold C Yang Journal: Am J Transplant Date: 2002-07 Impact factor: 8.086
Authors: Jennifer Flynn; Randi Zlotnik Shaul; Mark D Hanson; Gregory H Borschel; Ronald Zuker Journal: Plast Surg (Oakv) Date: 2014 Impact factor: 0.947
Authors: Etienne Lorquet; Alexander Govshievich; André Chollet; Dominique M Tremblay; Daniel E Borsuk Journal: Plast Reconstr Surg Glob Open Date: 2021-01-25